COUR (Coursera, Inc.) Stock Analysis - SEC Filings

Coursera, Inc. (COUR) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, COUR trades at $5.25 with a market cap of $1.64B and a P/E ratio of -16.98. COUR moved -3.24% today. Year to date, COUR is -25.85%; over the trailing twelve months it is -39.59%. Its 52-week range spans $5.00 to $13.56. Analyst consensus is strong buy with an average price target of $8.42. Rallies surfaces COUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find COUR SEC filings?

Rallies organizes COUR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

COUR Key Metrics

Key financial metrics for COUR
MetricValue
Price$5.25
Market Cap$1.64B
P/E Ratio-16.98
EPS$-0.31
Dividend Yield0.00%
52-Week High$13.56
52-Week Low$5.00
Volume398
Avg Volume0
Revenue (TTM)$757.50M
Net Income$-51.00M
Gross Margin54.57%

Latest COUR News

Recent COUR Insider Trades

  • Insight Holdings Group, LLC sold 78.63K (~$447.31K) on May 18, 2026.
  • Cardenas Alan B sold 9.14K (~$50.45K) on May 18, 2026.
  • Cardenas Alan B sold 9.71K (~$57.48K) on Feb 17, 2026.

COUR Analyst Consensus

8 analysts cover COUR: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.42.

Common questions about COUR

Where can I find COUR SEC filings?
Rallies organizes COUR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show COUR 10-K and 10-Q filings?
Rallies organizes COUR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is COUR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for COUR. It does not provide personalized investment advice.
COUR

COUR